JENNIFER GARDNER, MD

Assistant Professor,
Division of Dermatology

Collaborating Member,
UW Center for One Health Research (COHR)

Contact Information

University of Washington
Box 354697
Seattle, WA 98195-6524
Clinic: 206-598-4067
Fax: 206-598-2267
jen1110@uw.edu

Seattle Cancer Care Alliance
825 Eastlake Avenue East
3rd Floor
Box 358050
Seattle, WA 98195-8050
New Patients: 206-288-1062

 

Return to Faculty Directory

Education and Training

Internal Medicine Internship, Pennsylvania Hospital, 2007 - 2008
Cutaneous Oncology Fellowship, University of Pennsylvania, 2007 - 2008
Dermatology Residency, University of Pennsylvania, 2008 - 2011
Co-Chief Resident, University of Pennsylvania, 2011

Clinical Educational Interests

One Health: a concept recognizing the health of humans, animals and their shared environment are interconnected (http://deohs.washington.edu/cohr/)

Cutaneous Zoonoses, Melanoma / Cutaneous Oncology and Pigmented Lesions

Representative Publications

Council ML, Gardner JM, Helms C, Liu Y, Cornelius LA, Bowcock AM.  Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.  Experimental Dermatology. 2008.

Liu Y, Helms, C, Liao W, Zaba LC, Duan S, Gardner J, Wise C, Miner A, Malloy MJ, Pullinger C, Kane J, Saccone S, Worthington J, Bruce I, Kwok P-Y, Menter A, Krueger J, Barton A, Saccone NL, Bowcock AM.  A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet. 2008 Mar 28;4(3):e1000041.

Gardner JM, Introcaso CE, Nasta SD, Kim EJ, Vittorio CC, Rook AH.  A novel regimen of vorinostat with interferon gamma for refractory Sezary syndrome.  (Accepted for publication, JAAD, 2009) Introcaso CE, Kim EJ, Gardner J, Junkins-Hopkins JM, Vittorio CC, Rook AH. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central

Gardner JM, Evans K, Goldstein S, Kim EJ, Vittorio CC, Rook AH.  Vorinostat for the treatment of bullous pemphigoid in the setting of advanced, refractory cutaneous T cell lymphomaArch Dermatol. 2009:145(9):985-8.

Council ML, Gardner JM, Helms C, Liu Y, Cornelius LA, Bowcock, AM.  Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.  Exp Dermatol. 2009;18(5):485-7.

Gardner JM, Evans KG, Musiek AC, Rook AH, Kim EJ. Update on the treatment of cutaneous T-cell lymphoma (CTCL).  Curr Opin Oncol. 2009;21(2):131-7.

Rapael BA, Shin DB, Suchin KR, Morrissey KA, Vittorio CC, Kim EJ, Gardner JM, Evans KG, Introcaso CE, Samimi SS, Gelfand JM, Rook AH.  High clinical response rate of Sezary Syndrome to immunomodulatory therapies: prognostic markers of response.  Arch Dermatol.  2011; 147 (12): 1410-5.

Klein RS, Dunlop JD, Samimi SS, Morrissey KA, Evans KG, Gardner JM, Introcaso CE, Vitorio CC, Rook AH, Micaily B, Kim EJ.  Improvement in peripheral blood disease burden in patients with Sezary syndrome and leukemic mycosis fungoides after total skin electron beam radiation.  J Am Acad Dermatol. 2013 Jun;68(6):972-7.

Shinohara MM, Nguyen J, Gardner J, Rosenbach M, Elenitsas R. The histopathologic spectrum of decorative tattoo complications.  J Cutan Pathol. 2012 Dec;39(12):1110-8.

For a complete listing of all publications, please email drmadmin@uw.edu

top of page